Xencor Inc/ US98401F1057 /
| 03/05/2024 22:00:00 | Chg. +0.4800 | Volume | Bid22:00:10 | Ask22:00:10 | High | Low |
|---|---|---|---|---|---|---|
| 24.1100USD | +2.03% | 437,491 Turnover: 7.75 mill. |
23.8900Bid Size: 500 | 24.2900Ask Size: 500 | 25.0900 | 24.0100 |
GlobeNewswire
04/12/2023
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business ...
GlobeNewswire
03/10/2023
Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for...
GlobeNewswire
05/09/2023
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to...
GlobeNewswire
25/03/2022
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
03/03/2022
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2021 Results and Provides Business Update
GlobeNewswire
01/03/2022
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...
GlobeNewswire
10/02/2022
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
13/01/2022
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration o...
GlobeNewswire
11/01/2022
GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply ...
GlobeNewswire
31/12/2021
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immun...
GlobeNewswire
17/12/2021
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatme...
GlobeNewswire
14/12/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...
GlobeNewswire
07/12/2021
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutation...
GlobeNewswire
22/11/2021
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
GlobeNewswire
17/11/2021
Sarepta Therapeutics Appoints Stephen L. Mayo, Ph.D., to its Board of Directors
GlobeNewswire
15/11/2021
CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
GlobeNewswire
03/11/2021
INmune Bio, Inc. Announces Third Quarter 2021 Results and Provides Business Update
GlobeNewswire
04/08/2021
INmune Bio, Inc. Announces Second Quarter 2021 Results and Provides Business Update
GlobeNewswire
02/08/2021
Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
GlobeNewswire
14/06/2021
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Di...
GlobeNewswire
25/03/2021
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
GlobeNewswire
23/03/2021
Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Deve...
GlobeNewswire
24/02/2021
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
